TLTrident Lifeline543616Quarterly results

Revised unaudited results for half year ended 30.09.2026 resubmitted after error in earlier update

Trident Lifeline has resubmitted its unaudited results for the half year ended 30.09.2026, saying there was an inadvertent error in the results shared on 26.10.2026.

By ScoutQuest · Tue 27 Oct 2026, 8:56 PM IST · 2 min read

Revenue from operations (H1 FY27)

Rs. 5,956.91 lakh

Net profit (H1 FY27)

Rs. 1,159.58 lakh

Basic EPS (H1 FY27)

9.70

What the company has shared

• The exchange update is the revised outcome of the board meeting held on 26th October, 2026, resubmitting the financial results because of an inadvertent error in the results shared on 26.10.2026.
• The company has expressed regret for the inconvenience and asked the exchange to consider the revised update.
• The document carries the unaudited standalone results with the statutory auditor's limited review report, and a limited review report on the unaudited consolidated results.

Standalone half year ended 30.09.2026 (INR in lacs)

• Revenue from operations: 5,956.91, against 4,625.86 in the half year ended 30.09.2025.
• Other income: 145.78, against 164.32; total income 6,102.69, against 4,790.17.
• Total expenses: 4,568.11, against 3,679.71.
• Profit before tax: 1,534.58, against 1,110.46; current tax 375.00, against 268.75.
• Net profit for the period: 1,159.58, against 841.71.
• Basic and diluted EPS: 9.70 each, against 7.26 each.

Standalone quarter ended 30.09.2026 (INR in lacs)

• Revenue from operations: 3,272.68, against 2,684.23 in the quarter ended 30.06.2026 and 2,744.03 in the quarter ended 30.09.2025.
• Net profit: 657.83, against 501.76 and 494.12 respectively.
• Basic and diluted EPS: 5.50 each, against 4.26 and 4.30.

Balance sheet as at 30.09.2026 (INR in lacs)

• Total assets and total equity and liabilities: 17,456.89, against 15,919.06 as at 31.03.2026.
• Reserves and surplus: 9,563.55, against 8,342.52; share capital 1,195.70, against 1,193.30.
• Long-term borrowings: 2,130.82, against 670.98; short-term borrowings 2,100.17, against 1,788.47.
• Trade receivables: 4,302.47, against 4,934.11; inventories 2,477.88, against 2,321.87.

Auditor's view

• A Bafna & Associates, Chartered Accountants, reviewed the unaudited standalone results for the half year ended 30th September, 2026. Their report states that nothing came to their attention that causes them to believe the statement contains any material misstatement.
• A separate limited review report covers the unaudited consolidated results of the parent and its subsidiaries: TNS Pharma Private Limited, TLL Parenterals Limited, Trident Mediquip Limited, TLL Elements Private Limited and TLL Wellness Limited (formerly TLL Herbal Limited).

Other points in the notes

• Investor complaints: Nil pending at the beginning of the period, Nil received, Nil disposed of and resolved, Nil pending at the end.
• The company states it is listed on the SME Platform of BSE and has prepared the accounts under Indian GAAP.

What a retail investor can take away

• The numbers above are from the revised statement, so they replace what was shared earlier for this period.
• Both the half-year and the September quarter show revenue and profit above the corresponding year-ago figures, alongside higher long-term and short-term borrowings than at 31.03.2026.

Nothing here is a view, opinion or recommendation of ScoutQuest, its parent, directors or employees. ScoutQuest is a technology company: this page was assembled automatically from public sources using artificial intelligence, and may contain errors or omissions. Confirm everything against the original source before you act on it. Any use of this page is at your own risk, and neither ScoutQuest nor its parent, directors or employees accepts liability for it.

About ScoutQuest · Logos provided by Logo.dev